Planet Biotechnology Overview
- Year Founded
-
1994
- Status
-
Private
- Employees
-
5
- Latest Deal Type
-
Grant
- Latest Deal Amount
-
$260K
- Investors
-
4
Planet Biotechnology General Information
Description
Developer of antibody-based therapeutics created from plants. The company offers monoclonal therapeutic and preventative products using receptor/ligand fusion proteins through the cultivation of genetically modified green plants, enabling medical professionals to use them for the treatment and prevention of disease and meet significant underserved medical needs.
Contact Information
Website
www.planetbiotechnology.comCorporate Office
- 20980 Corsair Boulevard
- Hayward, CA 94545
- United States
Corporate Office
- 20980 Corsair Boulevard
- Hayward, CA 94545
- United States
Planet Biotechnology Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Grant | 31-Dec-2020 | $260K | 00.000 | Completed | Generating Revenue | |
| 6. Grant | 17-Jul-2020 | 000 | 00.000 | Completed | Generating Revenue | |
| 5. Grant | 01-Aug-2019 | 00000 | 00.000 | Completed | Generating Revenue | |
| 4. Grant | 04-Jul-2018 | 00000 | 00.000 | Completed | Generating Revenue | |
| 3. Grant | 14-Aug-2015 | 000.00 | 00.000 | Completed | Generating Revenue | |
| 2. Angel (individual) | 25-Jul-2014 | $761K | $1.33M | Completed | Generating Revenue | |
| 1. Angel (individual) | 06-Nov-2006 | $570K | $570K | Completed | Generating Revenue |
Planet Biotechnology Comparisons
Industry
Financing
Details
000000
000000
Planet Biotechnology Competitors (5)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Egenesis | Venture Capital-Backed | Cambridge, MA | 000 | 00000 | 00000000000 | 00000 |
| Intellia Therapeutics | Formerly VC-backed | Cambridge, MA | 000 | 00000 | 000000 - 000 | 00000 |
| Genentech | Formerly VC-backed | South San Francisco, CA | 00000 | 00.000 | 00000000000 | 00.000 |
| Amgen | Formerly PE-Backed | Thousand Oaks, CA | 00000 | 000.00 | 000000000 - | 000.00 |
| Boehringer Ingelheim | Corporation | Ingelheim Am Rhein, Germany | 00000 |
Planet Biotechnology Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Planet Biotechnology Patents
Planet Biotechnology Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4213887-A1 | Factor h fragment fc fusions with improved potency and manufacturability | Pending | 16-Sep-2020 | 00000000000 | |
| CA-3192583-A1 | Factor h fragment fc fusions with improved potency and manufacturability | Pending | 16-Sep-2020 | 000000000 | |
| US-20230357338-A1 | Factor h fragment fc fusions with improved potency and manufacturability | Pending | 16-Sep-2020 | 00000000000 | |
| US-20220002699-A1 | Ace2-fc fusion proteins for sars-cov-2 mitigation | Inactive | 07-Mar-2020 | 000000000 | |
| EP-3227318-A1 | Dpp4 immunoadhesin compositions and methods | Inactive | 05-Dec-2014 | C12N9/485 |
Planet Biotechnology Executive Team (2)
| Name | Title | Board Seat |
|---|---|---|
| Elliott Fineman | Chief Executive Officer, President & Board Member | |
| James Larrick Ph.D | Chief Scientific Officer & Vice President |
Planet Biotechnology Board Members (3)
| Name | Representing | Role | Since |
|---|---|---|---|
| Jeffrey Price | Self | Chairman | 000 0000 |
| Robert Tufts JD | Self | Board Member | 000 0000 |
| Ronald Cape | Self | Board Member | 000 0000 |
Planet Biotechnology Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Planet Biotechnology Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| United States Department of Defense | Government | 000 0000 | 000000 0 | |
| National Institutes of Health | Government | 000 0000 | 000000 0 | |
| National Institute Of Allergy and Infectious Diseases | Government | 000 0000 | 000000 0 | |
| Alex Day | Angel (individual) | Minority | 000 0000 | 000000 0 |
Planet Biotechnology FAQs
-
When was Planet Biotechnology founded?
Planet Biotechnology was founded in 1994.
-
Who is the CEO of Planet Biotechnology?
Elliott Fineman is the CEO of Planet Biotechnology.
-
Where is Planet Biotechnology headquartered?
Planet Biotechnology is headquartered in Hayward, CA.
-
What is the size of Planet Biotechnology?
Planet Biotechnology has 5 total employees.
-
What industry is Planet Biotechnology in?
Planet Biotechnology’s primary industry is Biotechnology.
-
Is Planet Biotechnology a private or public company?
Planet Biotechnology is a Private company.
-
What is Planet Biotechnology’s current revenue?
The current revenue for Planet Biotechnology is 000000.
-
How much funding has Planet Biotechnology raised over time?
Planet Biotechnology has raised $1.33M.
-
Who are Planet Biotechnology’s investors?
United States Department of Defense, National Institutes of Health, National Institute Of Allergy and Infectious Diseases, and Alex Day have invested in Planet Biotechnology.
-
Who are Planet Biotechnology’s competitors?
Egenesis, Intellia Therapeutics, Genentech, Amgen, and Boehringer Ingelheim are competitors of Planet Biotechnology.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
